Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma

Off Health, Health Information, Human Health, Science and Health, Science and Research, Science Daily, Uncategorized

A study has found that the addition of brentuximab vedotin to standard chemotherapy treatment improves overall survival in patients with Hodgkin Lymphoma, when compared to the current standard of chemotherapy alone.
Read Original Article: Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma »

About The Author